Business context and reporting period
Chemung Financial Corporation is a New York-based financial holding company whose subsidiaries provide banking, lending, fiduciary, investment advisory and insurance services. This unaudited Form 10-Q covers the three months ended March 31, 2015; comparisons for income and cash flow are against Q1 2014, and balance-sheet movements are generally against December 31, 2014. Amounts below are in U.S. dollars; financial statement figures are in millions unless noted.
Key financial metrics
| Metric | Q1 2015 / March 31, 2015 | Comparison |
|---|---|---|
| Net interest income | $12.34 million | Up 2.6% from $12.03 million in Q1 2014 |
| Non-interest income / expense | $5.19 million / $13.74 million | Income up 4.5%; expense up 2.9% year over year |
| Pre-provision income | $3.79 million | Up 3.8% from $3.65 million |
| Provision for loan losses | $0.39 million | Down 39.0% from $0.64 million |
| Net income / diluted EPS | $2.28 million / $0.48 | Up 10.3% / from $2.06 million / $0.44 |
| Net interest margin, fully taxable equivalent | 3.49% | Down 9 basis points from 3.58% |
| Return on average assets / equity | 0.59% / 6.79% | Q1 2014: 0.56% / 5.93% |
| Total assets / loans, net of allowance | $1,584.8 million / $1,129.7 million | Assets up 4.0% year over year; loans up 2.0% from year-end |
| Deposits / shareholders’ equity | $1,368.1 million / $136.3 million | Deposits up 6.9% from year-end; equity up 2.0% |
| Cash and cash equivalents | $84.9 million | Up $55.7 million from year-end, mainly from seasonal municipal deposits |
| Borrowings and other debt | $53.3 million; no FHLBNY overnight advances outstanding | Down $29.4 million from year-end |
| Operating / investing / financing cash flow | $3.44 million / $(5.38) million / $57.65 million | Q1 2014: $2.59 million / $(19.38) million / $22.33 million |
Material changes and management commentary
- Higher commercial-loan income, lower interest expense and stronger wealth-management fees supported earnings growth. The lower loan-loss provision also contributed; these benefits were partly offset by lower securities income and higher operating expenses and taxes.
- Commercial loans grew, while indirect consumer loans declined. Management attributed the latter to ending a reduced-pricing loan program in Q3 2014. Management expects future portfolio growth to be concentrated in commercial mortgages and commercial and industrial lending.
- Wealth Management Group fees increased 12.9% year over year; assets under management or administration were $1.979 billion at quarter-end, up 1.2% from December 31, 2014.
- Employee benefit expense rose $0.37 million, primarily following updated mortality assumptions and a lower discount rate used in pension cost calculations.
- Nonperforming loans were $10.42 million, or 0.91% of loans, compared with $7.78 million, or 0.69%, at year-end. Nonperforming assets were $12.93 million, or 0.82% of assets. The allowance was $13.89 million, 1.21% of loans, versus 1.22% at year-end; net charge-offs were $0.18 million.
- Deposits increased seasonally, particularly municipal money-market balances. The company used the inflow to repay $30.83 million of overnight FHLBNY advances. It reported $119.5 million of potential FHLBNY borrowing capacity and $28.0 million of available unsecured bank credit lines.
- Both the Corporation and the Bank exceeded applicable regulatory capital requirements for well-capitalized status. At the Bank, Basel III common equity Tier 1, Tier 1 risk-based, total risk-based and Tier 1 leverage ratios were 10.30%, 10.30%, 11.55% and 7.54%, respectively.
Outlook, risks, contingencies and unusual items
- No quantitative earnings or margin guidance was provided. Management said it was cautious about investing seasonal cash given the low interest-rate environment.
- Management identified interest-rate risk as its most significant market risk. Its modeled 200-basis-point rate decrease and increase would reduce next-12-month net interest income by 10.11% and 8.76%, respectively; both were within its 15% policy limit. Credit quality, economic conditions, competition, regulatory changes and the ability to manage growth were also cited as risks.
- A New York Surrogate’s Court approved settlements of litigation involving the Bank’s Wealth Management Group. The Bank agreed to pay $12.1 million; the balance sheet included a $12.1 million legal accrual and a $7.9 million insurance receivable at March 31. After quarter-end, all insurance proceeds were received and the settlements were paid. The filing states the company was appropriately reserved at December 31, 2014.
- Unrealized securities losses were considered temporary and primarily related to interest rates, not credit quality; management said it did not intend, and was not likely required, to sell affected securities before recovery. The filing also notes that the Q1 2014 comparison included a $0.5 million gain from liquidation of a trust-preferred-securities pool.
- Management said disclosure controls were effective at March 31, 2015, and reported no material change in internal control over financial reporting during the quarter. No material changes to the 2014 Form 10-K risk factors were reported.
Important facts for investors to verify
- Whether the rise in nonperforming loans—especially in commercial lending—continues, and how loss reserves and charge-offs develop.
- Whether seasonal municipal deposits persist and how deposit composition, CDARS/ICS funding and borrowing needs change.
- Whether loan growth and fee income can offset continued pressure on loan yields and net interest margin.
- The final cash and accounting effects of the $12.1 million settlement and related insurance recovery, including any potential residual exposure.
- Capital ratios and interest-rate sensitivity under the Basel III framework and changing market conditions.